Clinical applications of gas chromatography and gas chromatography-mass spectrometry of steroids (Q33683948)

28 July 2017

1 reference

title

Clinical applications of gas chromatography and gas chromatography-mass spectrometry of steroids (English)

1 reference

28 July 2017

Wolthers BG

1

1 reference

28 July 2017

Kraan GP

series ordinal

2

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

Journal of Chromatography

28 July 2017

published in

1 reference

28 July 2017

volume

843

1 reference

28 July 2017

issue

1-2

1 reference

28 July 2017

page(s)

247-274

1 reference

IUPAC-IUB revised tentative rules for nomenclature of steroids

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Gas-liquid partition chromatography; the separation and micro-estimation of volatile fatty acids from formic acid to dodecanoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Vapor Phase Chromatography and Telegrapher's Equation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

High resolution gas chromatography of urinary steroids on glass capillary columns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

An investigation of glasses for capillary chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Standardization of steroid hormone assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

International Federation of Clinical Chemistry. Committee on Standards. Expert Panel on Nomenclature and Principles of Quality Control in Clinical Chemistry. Approved recommendation (1978) on quality control in clinical chemistry. Part 1. General pr

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Candidate reference method for determining serum cortisol based on isotope dilution-gas chromatography/mass spectrometry using heptafluorobutyrilation as derivatization method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Serum testosterone determination by mass fragmentography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Plasma cortisol determination by mass fragmentography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Candidate definitive method for the determination of cortisol in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Validation of routine methods for serum progesterone determination using mass fragmentography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Determination of steroid hormones by the use of isotope dilution-mass spectrometry: A definitive method in clinical chemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Use of cyclodextrins for prepurification of progesterone and testosterone from human serum prior to determination with isotope dilution gas chromatography/mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Determination of aldosterone in human serum by isotope dilution gas chromatography/mass spectrometry using a new heptafluorobutyryl derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Measurement of plasma testosterone by gas chromatography-negative-ion mass spectrometry using pentafluoropropionic derivatives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Determination of plasma testosterone by mass fragmentography using [3,4-13C]testosterone as an internal standard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Validation of methods for determination of urinary estriol during pregnancy using mass fragmentography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Standardization of steroid immunoassays--in theory an easy task

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Problems in diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Androgen metabolism assessment by routine gas chromatography/mass spectrometry profiling of plasma steroids: Part 1, Unconjugated steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Simultaneous measurements of endogenous and deuterium-labelled tracer variants of androstenedione and testosterone by capillary gas chromatography-mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

The determination of delta-5-androstenediol and its sulphate in serum and urine by gas chromatography-mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Simultaneous quantitation of endogenous levels of cortisone and cortisol in human nasal and bronchoalveolar lavage fluids and plasma via gas chromatography-negative ion chemical ionization mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Quantitation of cortisol and related 3-oxo-4-ene steroids in urine using gas chromatography/mass spectrometry with stable isotope-labeled internal standards.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Sexualhormone X. Herstellung des 17-Methyl-testosterons und anderer Androsten- und Androstanderivate. Zusammenhänge zwischen chemischer Konstitution und männlicher Hormonwirkung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Testing for natural and synthetic anabolic agents in human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Separation and confirmation of anabolic steroids with quadrupole ion trap tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Excretion study of furazabol, an anabolic steroid, in human urine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Long-term detection and identification of metandienone and stanozolol abuse in athletes by gas chromatography-high-resolution mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Extraction of steroid conjugates with a neutral resin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Use of sep-pak ® cartridges for urinary steroid extraction: evaluation of the method for use prior to gas chromatographic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

The multicomponent analysis of estrogens in urine by ion exchange chromatography and GC-MS--I. Quantitation of estrogens after initial hydrolysis of conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Profiling steroid hormones and urinary steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Chromatography as a reference technique for the determination of clinically important steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Quantitative analysis of steroid profiles from urine by capillary gas chromatography. I. Accuracy and reproducibility of the sample preparation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Androstanediol and 5-androstenediol profiling for detecting exogenously administered dihydrotestosterone, epitestosterone, and dehydroepiandrosterone: potential use in gas chromatography isotope ratio mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Confirming testosterone administration by isotope ratio mass spectrometric analysis of urinary androstanediols.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Increased urinary testosterone/epitestosterone ratios found in Swedish athletes in connection with a national control program. Evaluation of 28 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

On the origin of physiologically high ratios of urinary testosterone to epitestosterone: consequences for reliable detection of testosterone administration by male athletes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Combined profile of androgen glucuro- and sulfoconjugates in post-competition urine of sportsmen: a simple screening procedure using gas chromatography-mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Criteria to indicate testosterone administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Possible indices for the detection of the administration of dihydrotestosterone to athletes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Gas chromatography/combustion/isotope-ratio mass spectrometry analysis of urinary steroids to detect misuse of testosterone in sport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Improved method of detection of testosterone abuse by gas chromatography/combustion/isotope ratio mass spectrometry analysis of urinary steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Detection of testosterone misuse: comparison of two chromatographic sample preparation methods for gas chromatographic-combustion/isotope ratio mass spectrometric analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

High doses of alcohol increase urinary testosterone-to-epitestosterone ratio in females.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Profiling of urinary testosterone and luteinizing hormone in exercise-stressed male athletes, using gas chromatography-mass spectrometry and enzyme immunoassay techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Clinical indications for the use of urinary steroid profiles in neonates and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Urine steroid excretion rates in childhood reflect growth and activity of the adrenal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Determination of urinary 17-hydroxypregnanolone by gas chromatography-mass spectrometry in patients with congenital adrenal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

The early recognition of the 21-hydroxylase deficiency variety of congenital adrenal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Identification of 15 beta-hydroxylated C21 steroids in the neo-natal period: the role of 3 alpha,15 beta,17 alpha-trihydroxy-5 beta-pregnan-20-one in the perinatal diagnosis of congenital adrenal hyperplasia (CAH) due to a 21-hydroxylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Congenital adrenal hyperplasia caused by defect in steroid 21-hydroxylase. Establishment of definitive urinary steroid excretion pattern during first weeks of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

New identified 15 beta-hydroxylated 21-deoxy-pregnanes in congenital adrenal hyperplasia due to 21-hydroxylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Metabolism of Radiolabeled Corticosterone in an Adult with the 17α-Hydroxylase Deficiency Syndrome*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Measurement of the cortisol production rate in two sisters with 17 alpha-hydroxylase deficiency using [1,2,3,4-13C]cortisol and isotope dilution mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Synthesis and identification of twelve A-ring reduced 6 alpha- and 6 beta-hydroxylated compounds derived from 11-deoxycortisol, corticosterone and 11-dehydrocorticosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Kinetics and metabolism of 11-deoxycortisol in a patient with congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Detection of 3 beta-hydroxysteroid dehydrogenase deficiency in a newborn by means of urinary steroid analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Urinary steroidal pattern of infants with congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Detection of 3 beta-hydroxysteroid-dehydrogenase deficiency by urinary steroid profiling: solvolysis of urinary samples should be a necessary prerequisite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Analysis of steroids in urine for differentiation of pseudohypoaldosteronism and aldosterone biosynthetic defect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Urinary steroid profile of a newborn suffering from pseudohypoaldosteronism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Improved gas chromatographic-mass fragmentographic assay for tetrahydroaldosterone and aldosterone in urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

An abnormality in steroid reductive metabolism in a hypertensive syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Apparent mineralocorticoid excess: type I and type II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Licorice-induced hypermineralocorticoidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

A new defect in the peripheral conversion of cortisone to cortisol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900153-3

10.1016/S0021-9673(99)00153-3

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference